SCHEMBL2035290

SCHEMBL2035290

[CH2][CH]c1cc(Cl)c2cccnc2c1N1CCN(C(=O)c2cnccn2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.42
HSD17B10 Q99714 4/20 0.42
LMNA P02545 1/20 0.42
GBA1 P04062 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
CYP2D6 P10635 3/20 0.41
CYP2C19 P33261 3/20 0.41
NAMPT P43490 1/20 0.40
GAA P10253 1/20 0.39
CYP1A2 P05177 4/20 0.39
USP2 O75604 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C9 P11712 2/20 0.39
CASP1 P29466 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2163506 0.84 GBA1 (0.45) CYP3A4HSD17B10LMNAGBA1ALDH1A1
SCHEMBL2015058 0.83 GBA1 (0.45) CYP3A4HSD17B10LMNAGBA1ALDH1A1
SCHEMBL2164804 0.81 GBA1 (0.43) CYP3A4HSD17B10LMNAGBA1ALDH1A1
SCHEMBL2017545 0.81 GBA1 (0.43) CYP3A4HSD17B10LMNAGBA1ALDH1A1
SCHEMBL2016485 0.73 PIK3CD (0.41) CYP3A4HSD17B10LMNAGBA1ALDH1A1
SCHEMBL2053755 0.73 L3MBTL1 (0.51) HSD17B10LMNAALDH1A1HPGDGAA
SCHEMBL2015986 0.72 L3MBTL1 (0.48) HSD17B10LMNAALDH1A1HPGDGAA
SCHEMBL2016487 0.72 GBA1 (0.35) CYP3A4HSD17B10LMNAGBA1ALDH1A1
SCHEMBL2163899 0.71 MEN1 (0.54) LMNAALDH1A1SMN1; SMN2MAPK1MEN1
SCHEMBL2014280 0.71 MEN1 (0.52) CYP3A4LMNAALDH1A1CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed